Personalized and Precision Probiotics Market Size is predicted to witness a 5.74% CAGR during the forecast period for 2023-2031.
Probiotics are live organisms that are beneficial for individuals and provide health advantages. Probiotics work for microbiome management, pathogen suppression, epithelial cell growth, immunomodulation, and gut barrier fortification.
Personalized and precision probiotics are tailor-made microbiome products that consider individual microbiomes. The product range encompasses exclusively probiotics that are derived from the microbiome, precision probiotics, personalized probiotics, probiotics provided after microbiome testing, and customized probiotics delivered following microbiome testing.
Personalized probiotics are specifically tailored to the individual's gut microbiome by analyzing the person's stool sample to identify the specific bacteria that are missing or out of balance. Precision probiotics consider a wider range of factors, including medical history, lifestyle, and diet, apart from individual microbiomes.
Personalized and precision probiotics are preferred as these are formulated according to individuals' unique gut health needs. They help improve digestion, reduce inflammation, gas and bloating, and increase energy levels.
The increasing demand for natural and organic products and the rising prevalence of digestive disorders are expected to enhance the market revenue growth during the forecast period.
Competitive Landscape
Some of the Key Players in the Personalized and Precision Probiotics Market:
- Amway Korea
- Sun Genomics
- Viome Life Sciences, Inc.
- GUTolution
- Genefitletics
- Other Prominent Players
Market Segmentation:
The Personalized and Precision Probiotics Market is segmented based on application and end-user. The application segment includes gut health, mental performance (brain fog, sleep issues, mood issues, attention deficit hyperactivity disorder (ADHD), autism spectrum disorder), and others (sleep issues, eczema, joint pain, oral health, vaginal health). By end-user, the market is divided into adults, children, and teenagers.
The gut health segment accounted for the largest revenue share of the personalized and precision probiotics market in 2022.
By application, the gut health segment accounted for the largest revenue share of the personalized and precision probiotics market in 2022. Probiotic supplements are an effective and convenient way to introduce beneficial bacteria into the gut, becoming increasingly popular among consumers. The rising importance of gut health in overall well-being has increased the demand for personalized and precision probiotics. In addition, the high prevalence of chronic diseases is expected to boost the need for probiotics to control conditions such as inflammatory bowel disease (IBD), diarrhoea, and colon cancer.
The adults segment witnessed the fastest growth in 2022.
By end-user, the adults segment is likely to witness the fastest growth over the forecast period owing to the increasing digestive problems and rising health consciousness among adults.
Regionally, North America led the personalized and precision probiotics market in 2022.
North America is estimated to capture the highest revenue share for the personalized and precision probiotics market over the forecast years due to factors such as the increasing research investments in innovating natural and personalized health supplements and the growing awareness regarding healthy lifestyles. Moreover, the Asia Pacific market accounted for the second-largest revenue share in 2022. The factors contributing to this growth are the high demand for healthy and organic products, increasing digestive health issues, R&D activities for personalized medicines, and the growing importance of gut health in overall well-being. In addition, the European market is likely to witness considerable growth in the upcoming years.
Personalized and Precision Probiotics Market Report Scope
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 5.74 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Application, End-user |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia |
|
Competitive Landscape |
Amway Korea, Sun Genomics, Viome Life Sciences, Inc., GUTolution, Genefitletics, and Others. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
